2015
DOI: 10.5761/atcs.oa.14-00261
|View full text |Cite
|
Sign up to set email alerts
|

Effects of Continuous Infusion of Low-dose Human Atrial Natriuretic Peptide (hANP) on the Lungs during Cardiac Surgery

Abstract: Objective: The objective of this study was to determine the effects of a continuous infusion of low-dose hANP on the lungs during cardiac surgery in patients under cardiopulmonary bypass (CPB). Methods: We analyzed 30 consecutive cases of cardiac surgery performed at our hospital from 2007-2008. The patients were divided into a group that received hANP (hANP group) or a group that received saline and no hANP (N-hANP group). We measured various parameters before and after surgery using a PiCCO monitor. Result: … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2016
2016
2018
2018

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(2 citation statements)
references
References 21 publications
0
2
0
Order By: Relevance
“…TLR4 plays an important role in surgery-induced systemic inflammation (34). Several clinical studies, including ours and those of other groups, showed that cGMP induction treatment is a promising strategy for suppressing systemic inflammation in patients during the perioperative period (35,36). In addition, in our clinical study, patients received cGMP inducer ∼1 h before the start of pulmonary resection.…”
Section: Discussionmentioning
confidence: 70%
“…TLR4 plays an important role in surgery-induced systemic inflammation (34). Several clinical studies, including ours and those of other groups, showed that cGMP induction treatment is a promising strategy for suppressing systemic inflammation in patients during the perioperative period (35,36). In addition, in our clinical study, patients received cGMP inducer ∼1 h before the start of pulmonary resection.…”
Section: Discussionmentioning
confidence: 70%
“…Shibasaki et al found no difference in the pulmonary blood volume index, extravascular lung water index, and pulmonary vascular permeability index between the patients treated with carperitide or placebo, but urine volume was significantly higher and the interleukin-6 and albumin levels were significantly lower in the carperitide group. Accordingly, Shibasaki et al concluded that carperitide reduces thirdspace fluid retention caused by CPB [48].…”
Section: Pulmonary Protection By Natriuretic Peptides In Cardiac Surgery Patientsmentioning
confidence: 99%